Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOLUTEGRAVIR for Hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where DOLUTEGRAVIR was used for Hepatitis c.

Most Reported Side Effects for DOLUTEGRAVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 1,036 9.6% 93 66
Exposure during pregnancy 776 7.2% 110 95
Virologic failure 770 7.2% 16 61
Pathogen resistance 586 5.4% 2 13
Maternal exposure during pregnancy 517 4.8% 14 41
Viral mutation identified 510 4.7% 4 11
Treatment failure 453 4.2% 96 11
Drug ineffective 447 4.2% 133 55
Off label use 413 3.8% 116 48
Blood hiv rna increased 410 3.8% 12 28
Treatment noncompliance 409 3.8% 20 90
Immune reconstitution inflammatory syndrome 403 3.7% 58 208
Headache 401 3.7% 102 76
Pyrexia 398 3.7% 122 154
Death 397 3.7% 392 29

Other Indications for DOLUTEGRAVIR

Hiv infection (7,207) Product used for unknown indication (2,252) Antiretroviral therapy (241) Acquired immunodeficiency syndrome (149) Prophylaxis against hiv infection (95) Hiv test positive (77) Maternal exposure timing unspecified (49) Hepatitis b (30) Antiviral treatment (24) Acute hiv infection (23)

Other Drugs Used for Hepatitis c

RIBAVIRIN (20,657) PEGINTERFERON ALFA-2A (10,970) LEDIPASVIR\SOFOSBUVIR (8,924) DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (8,264) SOFOSBUVIR (7,691) SOFOSBUVIR\VELPATASVIR (4,956) GLECAPREVIR\PIBRENTASVIR (4,016) OMBITASVIR\PARITAPREVIR\RITONAVIR (2,906) TELAPREVIR (2,604) DASABUVIR (2,603)

Related Pages

DOLUTEGRAVIR Full Profile All Hepatitis c Drugs DOLUTEGRAVIR Demographics DOLUTEGRAVIR Timeline